Quinn.
Quinn is an entrepreneur who happens to be perimenopausal. By the time she arrived in my care, she had been managing a multi-system picture for years: fatigue that no longer recovered with rest, weight that had stopped moving on diets that used to work, sleep that woke her at three a.m., fibroids, sciatica, and a small thyroid nodule that had been quietly there for long enough to lose its alarm value but not long enough to ignore.
She had been told, more than once, that her thyroid was fine. The standard test had been done and was “normal.” The conversation had ended there.
It had not ended for her body. The symptoms were real, and not “just in her head.”
The Deeper Challenge.
At my recommendation, a deeper screening panel was ordered. Most practitioners only run TSH. The fuller panel (free T4, free T3, reverse T3, and antibody markers alongside TSH) surfaced what had been missed. TSH and free T4 were elevated for her age demographic, and anti-TPO antibodies were also elevated. The pattern was the long lead-in phase of an autoimmune thyroid process, the years before the standard threshold for diagnosis is crossed.
Underneath the thyroid presentation sat a perimenopausal hormone landscape, multiple uterine fibroids, an iodine-deficient developmental terrain that nobody had thought to ask about, and a low-grade adrenal pattern that would become more visible as care progressed.
This was not a thyroid case. It was a multi-axis case with thyroid as the most visible thread.
The Process.
The first months focused on the immune drivers: castor oil packs, thyroid-supportive nutrients, iron repletion, a menopausal hormone tincture, and a homeopathic constitutional protocol. We named the prescriber’s options on the table early, so she and her prescriber could decide together, in time, whether and when conventional thyroid medication would join the protocol.
By month one, her gynaecologist confirmed the fibroid was shrinking and the uterus was softer. Sciatica resolved within the first two months. Sleep stabilized.
The deeper immune work took the rest of the first seven months. Gluten became a strict avoidance, a real compliance challenge early that eventually became reliable. By month seven, antibody activity had begun trending downward, and the autoimmune trajectory appeared to stabilize.
Year two layered in conventional thyroid hormone (desiccated thyroid), with dosing refined alongside her prescriber. Inflammation appeared in the joints, driven by pandemic-era stress that cycled the system repeatedly, while ongoing family stress put recurring strain on the work she was doing for her health.
Key Turning Points.
The pivotal year came at year three. Her thyroid markers had stopped getting worse, but they had also stopped optimizing. Her energy had slipped into prolonged exhaustion. Weight had gained and stopped responding to the dietary work that had previously been effective.
The picture had reorganized: the HPA axis, her stress-response and adrenal system, had become the primary driver, and the thyroid was reflecting that upstream state.
We pivoted to adrenal glandular support, therapeutic vitamin C, and a focus on protein in the mornings to support the adrenals. Intermittent fasting was introduced once the system was stable enough to support it, alongside brisk walking at a sustained heart rate. Within weeks, her energy returned. Within months, joint inflammation eased, sleep steadied, and the weight loss began moving again.
Outcome.
After approximately three years of multi-phase work, Quinn has recovered from the prolonged exhaustion and inflammation that had been compromising her capacity. Joint, sleep, and energy issues all resolved, and her body is reliable through ordinary work demands. The fibroid has remained shrunk. The sciatica has stayed resolved. The autoimmune trajectory shifted years ago and has remained on that side.
Her thyroid markers are stable but not yet optimal. Fine-tuning thyroid output and the last of the metabolic optimization is ongoing.
What is also real is that the system underneath is no longer fragile. It does not collapse under pressure the way it used to. The work that remains is fine-tuning within a structure that has been substantially restored.
Key Takeaway.
What looks like a thyroid problem is often a much larger systems issue. In Quinn’s case, the real story ran through autoimmune drivers, perimenopausal terrain, an iodine-deficient developmental history that the standard intake never asks about, and an HPA axis that had been depleting for years. When a chronic thyroid case stops responding to thyroid-directed work alone, the answer is almost never a stronger thyroid medication. It is the layers underneath, addressed as one integrated system and sequenced over time.
If you recognize your own system in what you just read, the PRO Method is the framework I use to address it. Book an initial consultation to see what restoration would look like for you.
All names have been changed. Details adjusted to protect privacy.